illustration of medical expert using a looking glass

Image source: Shutterstock/Lightspring

Microbiological big data analysis

Building a 'Microbiome Search Engine'

Big data makes big promises when it comes to providing insights into human behavior and health. The problem is how to harness the information it provides in an efficient manner.

An international team of researchers has proposed a microbiome search-based method, via Microbiome Search Engine (MSE), to analyze the wealth of available health data to detect and diagnose human diseases. They published their method in mSystems, a peer-reviewed open access journal of the American Society for Microbiology. "Microbiome-based disease classification depends on well-validated, disease-specific models or markers," said Dr. Xiaoquan Su, from Single-Cell Center at Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences (CAS). "However, current models are lacking that information for many diseases."

In light of the general shift of microbiome-sequencing focus from healthy to diseased hosts, the findings here advocate for adding more baseline samples from across different geographic locations

Rob Knight

In addition, Su said, multiple diseases can share the same biomarkers - the microorganisms that indicate something out of the ordinary, such as a mutated protein found in cancer cells, making it harder for researchers to correctly classify each one. To combat these issues for disease detection and classification, Su and his joint software team from Single-Cell Center, QIBEBT and Center for Microbiome Innovation (CMI), University of California at San Diego (UCSD), developed a new search approach based on the whole microbial community a human body contains, collectively called the microbiome. Every person has a microbiome, even if they do not have a disease.

Traditional models compare samples from healthy subjects to those from people known to have specific diseases. With the new method, by searching based on the specific outlier, rather than known biomarkers that can code for several diseases, the researchers can identify the microbiome state associated with the disease across different cohorts or sequencing platforms.

Recommended article

Photo

Interdisciplinary

Exploring the human microbiome

During the International Forum for Laboratory Medicine, one seminar focused on infectious diseases. Professor André Gessner, from the Medical Microbiology and Hygiene Department at Regensburg University, lectured on ‘The human microbiome, an explosive ‘climate’ topic,’ he explained.

In this new approach, the research team employs a two-step process to identify disease. First, they search a baseline database of healthy individuals to detect any specific microbiome outlier novelty - or any known anomaly that differentiates the microbiome from a healthy state. They then search for that outlier in a database of disease-specific examples. "Our strategy’s precision, sensitivity and speed outperform model-based approaches," Su said. The results of the search can provide quick predictions to help clinicians diagnose and treat diseases. "This search-based strategy shows promise as an important first step in microbiome big data-based diagnosis," according to Rob Knight, Director of CMI and UCSD. "In light of the general shift of microbiome-sequencing focus from healthy to diseased hosts, the findings here advocate for adding more baseline samples from across different geographic locations."

Jian Xu, Director of Single-Cell Center, QIBEBT, agrees. Next, the joint Sino-USA team is working towards encouraging their colleagues to join a coordinated effort to continue expanding the microbiome database, to include every population and every ecosystem on the globe. "With Microbiome Search Engine, performing a search can become as standard and enabling for new microbiome studies as performing a blast against your new DNA sequence is today." Xu said.


Source: Chinese Academy of Sciences

24.03.2020

Read all latest stories

Related articles

Photo

Mass spectrometry-based metabolomics

A new technique to understand metabolic pathways

Mass spectrometry-based metabolomics has emerged as a powerful tool to help study chemical ecology. Recent advances in the technique make it possible to study microbial interactions from complex…

Photo

Human-bacterial symbiosis

The value of the human microbiome

The human species maintains symbiotic relationships with a multitude of microbial organisms that colonise the inside as well as the surface of the body. Scientists, for a long time, underestimated…

Photo

Microbiome study

Do microscope eyepieces pose an infection risk?

Light microscope for viewing microorganisms such as bacteria and fungi are commonly found in scientific laboratories. A research team from Furtwangen University, the University of Tübingen and Carl…

Related products

Hund – medicus plus Myko

Microscopy

Hund – medicus plus Myko

Helmut Hund GmbH
i-Solutions Health – LabCentre

LIS, Middleware, POCT

i-Solutions Health – LabCentre

i-SOLUTIONS Health GmbH
Medat – Laboratory Information System

LIS, Middleware, POCT

Medat – Laboratory Information System

Medat Computer-Systeme GmbH
Olympus – CX33

Microscopy

Olympus – CX33

Olympus Europa SE & Co. KG
Shimadzu – Axima iDplus Assurance

Mass Spectrometry

Shimadzu – Axima iDplus Assurance

Shimadzu Europa GmbH
Shimadzu – Axima iDplus Confidence

Mass Spectrometry

Shimadzu – Axima iDplus Confidence

Shimadzu Europa GmbH